Grant: Project Grant
University of Calgary
$745,876.00
Targeting brain cholesterol homeostasis to counteract prion diseases
FY 2019-20
Summary
Many diseases of the brain are caused by proteins that change their three-dimensional shape, and as a consequence form 'clumps' or aggregates in brain cells, eventually destroying the brain. Prion diseases such as Creutzfeldt-Jakob disease are the prototype
group for such disorders. They are always fatal and cannot be treated to date. We found that cholesterol, an important component of cellular membranes, is elevated in prion-infected
neurons, which favors the aggregation of the disease-causing protein. We propose to elucidate the consequences of elevated cholesterol levels and use a re-purposed pharmaceutical as a new approach for treatment of prion diseases.
Department
Program
Project Grant
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
419868
Name
Gilch Sabine
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Targeting brain cholesterol homeostasis to counteract prion diseases
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$745,876
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cell Biology Of Prion Infection; Cholesterol Metabolism; Endocytic Vesicle Trafficking; Mouse Models Of Prion Disease; Neurodegeneration; Prion Disease; Treatment Of Prion Disease
Abstract
Many diseases of the brain are caused by proteins that change their three-dimensional shape, and as a consequence form 'clumps' or aggregates in brain cells, eventually destroying the brain. Prion diseases such as Creutzfeldt-Jakob disease are the prototype
group for such disorders. They are always fatal and cannot be treated to date. We found that cholesterol, an important component of cellular membranes, is elevated in prion-infected
neurons, which favors the aggregation of the disease-causing protein. We propose to elucidate the consequences of elevated cholesterol levels and use a re-purposed pharmaceutical as a new approach for treatment of prion diseases.
Competitiondate
202003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gilch, Sabine
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $745,876~ $0~